Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Bulgaria Croatia France Germany Hungary +6
  • Study of BIIB115 in patients aged 15‑60 years with spinal muscular atrophy who are treatment‑naïve or previously treated with risdiplam

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    Finland France Germany Ireland Italy Poland +1
  • Contraceptive efficacy, safety and tolerability of drospirenone 4 mg (LPRI‑CF113) in healthy women of reproductive age over 13 cycles

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    Czechia Finland Hungary Poland Romania Spain +1
  • Zodasiran for Adolescents With Homozygous Familial Hypercholesterolemia: A Phase 3 Study of Efficacy and Safety

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark The Netherlands Norway Poland Sweden
  • Omalizumab monotherapy for patients with vegetable (plant‑based food) allergy due to LTP and profilin sensitization

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain
  • Study on Cefepime and Enmetazobactam for Children with Complicated Urinary Tract Infections, Including Acute Pyelonephritis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Czechia France Hungary Poland Slovakia Spain
  • Live Attenuated Influenza Vaccine (LAIV) and Immune Response in the Nasopharynx of Young Children with Influenza

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Spain
  • Long-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium Czechia Denmark Finland France Germany +4
  • Study of BMN 351 given by intravenous infusion to evaluate safety and tolerability in patients with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Italy The Netherlands Spain